Vanda Pharmaceuticals Stock
Vanda Pharmaceuticals Stock
A loss of -1.600% shows a downward development for Vanda Pharmaceuticals.
Vanda Pharmaceuticals is currently one of the favorites of our community with 9 Buy predictions and no Sell predictions.
Based on the current price of 4.42 € the target price of 17 € shows a potential of 284.79% for Vanda Pharmaceuticals which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Vanda Pharmaceuticals stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Vanda Pharmaceuticals in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vanda Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vanda Pharmaceuticals | -1.600% | -5.960% | -17.575% | 18.128% | -28.742% | -16.642% | -67.986% |
| Evolus Inc | -2.840% | -0.496% | -14.130% | -33.154% | -4.330% | -42.703% | -41.085% |
| Heron Therapeutics Inc. | -1.990% | 2.964% | 15.558% | -71.508% | -61.329% | -69.229% | -95.846% |
| Rhythm Pharmaceuticals | -6.560% | 1.667% | -5.181% | 26.207% | -2.139% | 479.114% | 535.417% |
Comments
Vanda Pharmaceuticals (VNDA) had its "buy" rating reaffirmed by HC Wainwright.
Show more
Ratings data for VNDA provided by MarketBeat
Vanda Pharmaceuticals (VNDA) had its price target lowered by HC Wainwright from $24.00 to $21.00. They now have a "buy" rating on the stock.
Show more
Ratings data for VNDA provided by MarketBeat
Vanda Pharmaceuticals (VNDA) is now covered by Truist Financial Corporation. They set a "buy" rating and a $18.00 price target on the stock.
Show more
Ratings data for VNDA provided by MarketBeat